Aminosalicylate use suboptimal in ulcerative colitis

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.390, 2002-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Balsalazide: A Review of its Therapeutic Use in Mild-to-Moderate Ulcerative Colitis

By Muijsers R.B.R.   Goa K.L.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1689-1705

Adis International

Access to resources Recommend Favorite

MMX® Mesalazine: A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis

By Yang Lily P.H.   McCormack Paul L.  

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 221-235

Adis International

Access to resources Recommend Favorite

Delayed-release MMX™ mesalazine: a guide to its use in ulcerative colitis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 6-8

Adis International

Access to resources Recommend Favorite

Use of Cordia dichotoma bark in the treatment of ulcerative colitis

By Ganjare Anjali B.   Nirmal Sunil A.   Rub Ruksana A.   Patil Anuja N.   Pattan Shashikant R.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 8, 2011-08 ,pp. : 850-855

Informa Healthcare

Access to resources Recommend Favorite

Ulcerative Colitis: Pathogenesis

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1373-1382

Bentham Science Publishers

Access to resources Recommend Favorite